Project Title: Machine Perception Nanosensor Array Platform to Capture Whole Disease Fingerprints of Early Stage Pancreatic Cancer
Position: Assistant Professor
Institution: Georgia Tech
Funding NIH Institute/Center: National Institute of Biomedical Imaging and Bioengineering
Grant ID: R00EB033580
Mijin Kim grew up in South Korea. She became interested in material science and physical chemistry while working as an undergraduate research assistant in the analytical spectroscopy laboratory at Hanyang University in Korea. Dr. Kim moved to the United States to earn a doctorate in chemistry at the University of Maryland, College Park. During her PhD studies, she investigated the methods of chemical modification to improve the quantum efficiency and functionalities of carbon nanotubes. Now in her postdoctoral training in molecular pharmacology at the Sloan-Kettering Institute, Dr. Kim utilizes the chemically modified carbon nanotubes to address challenges in cancer diagnostics and biomedical research tools. She’s developed a machine-learning enabled nanosensor array platform to identify a disease fingerprint of ovarian cancer from patient sera. Dr. Kim currently investigates the molecular mechanism of sensor response and works on validating the methodology for another clinical target. Throughout her training, she’s been committed to promoting diversity in science and engineering through outreach at a local high school and through mentoring students from underrepresented minority and disadvantaged backgrounds.